Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_assertion type Assertion NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_head.
- NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_assertion description "[The strong inhibitory of the KIR ligand HLA-C2 protects against PSC development in all populations hitherto studied. Further studies on the role of natural killer cells and T-lymphocytes expressing KIRs in PSC pathogenesis are warranted.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_provenance.
- NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_assertion evidence source_evidence_literature NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_provenance.
- NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_assertion SIO_000772 20347497 NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_provenance.
- NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_assertion wasDerivedFrom gad-20150221 NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_provenance.
- NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_assertion wasGeneratedBy ECO_0000203 NP137175.RAdOkT-cSpK1Zz3T7JMdcJaA_nrVtov7ydkxLPiNWETDU130_provenance.